52周英夫利西疗程中第14周中性粒细胞与淋巴细胞比值可预测克罗恩患者是否对治疗产生失应答
高 倩,董红霞,李 瑾
Neutrophil-lymphocyte ratio at 14th week predicts loss ofresponse to 52-week infliximab therapy in patients withCrohn’s disease
南方医科大学学报 . 2020, (04): 453 -458 .  DOI: 10.12122/j.issn.1673-4254.2020.04.01